Actuate Therapeutics prices $15M public offering of 2.14M shares at $7.00/share

ACTUATE THERAPEUTICS, INC.

Offers 2,142,858 shares at $7.00/share; gross proceeds ~$15M before discounts and expenses.
Underwriters granted 30-day over-allotment option for up to 321,428 additional shares.
Closing expected September 11, 2025; proceeds for working capital and general corporate purposes.
Directors and executive officers subject to lock-up until December 9, 2025.
Lucid Capital Markets sole book-runner; Titan Partners Group as financial advisor.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.